Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Combination Therapy in Hypertension (eBook)

(Autor)

eBook Download: PDF
2013 | 2011
VII, 84 Seiten
Springer Healthcare (Verlag)
978-1-908517-28-9 (ISBN)

Lese- und Medienproben

Combination Therapy in Hypertension - Joel M. Neutel
Systemvoraussetzungen
46,00 inkl. MwSt
(CHF 44,90)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
For over 30 years, the stepped care approach has been used in the management and treatment of hypertension. This approach advocates the use of initial monotherapy to reach the desired blood pressure, and the subsequent use of additional drugs with complementary modes of action, until the target BP is achieved. However, current control rates for hypertension suggest that such an approach may be outdated and no longer effective in the management of hypertension. Clinical trials have shown that more than 50% of patients require a combination of drug therapies to achieve their target BP. Some proponents of combination therapy have argued that the risk of adverse side effects and non-compliance will be lower than that compared to monotherapy, which initially requires higher doses to be administered to be effective. Consequently, there have been increasing calls of the necessity for a much more combined approach in the treatment of hypertension. Adding to this, Combination Therapy in Hypertension will cover current control rates of blood pressure worldwide, the benefits of monotherapy and combination therapy, examine the effectiveness, risk of adverse effects, compliance, and cost of the available therapies and will also include information on relevant outcome studies.

Dr. Neutel is an innovative and leading specialist in clinical hypertension. He is Medical Director of Clinical Pharmacology at Orange County Research Center, Director of Research at Memorial research Medical Clinic in Long Beach, and Staff Physician at Long Beach Memorial Medical Center and the Veterans Affairs Medical Center. He is also a founding partner of Integrium, a research organisation which focuses on clinical trials in cardiovascular and metabolic disease. A prominent advocate of the need for combination therapy in the management of hypertension, Dr. Neutel has researched and lectured extensively on the subject and has authored numerous abstracts, journal articles and book chapters. He has also been a reviewer and served on the editorial boards for a number of high profile journals. A prolific researcher, he has carried out extensive research in areas such as cardiovascular medicine, endocrinology, and central nervous system disorders.
For over 30 years, the stepped care approach has been used in the management and treatment of hypertension. This approach advocates the use of initial monotherapy to reach the desired blood pressure, and the subsequent use of additional drugs with complementary modes of action, until the target BP is achieved. However, current control rates for hypertension suggest that such an approach may be outdated and no longer effective in the management of hypertension. Clinical trials have shown that more than 50% of patients require a combination of drug therapies to achieve their target BP. Some proponents of combination therapy have argued that the risk of adverse side effects and non-compliance will be lower than that compared to monotherapy, which initially requires higher doses to be administered to be effective. Consequently, there have been increasing calls of the necessity for a much more combined approach in the treatment of hypertension. Adding to this, Combination Therapy in Hypertension will cover current control rates of blood pressure worldwide, the benefits of monotherapy and combination therapy, examine the effectiveness, risk of adverse effects, compliance, and cost of the available therapies and will also include information on relevant outcome studies.

Dr. Neutel is an innovative and leading specialist in clinical hypertension. He is Medical Director of Clinical Pharmacology at Orange County Research Center, Director of Research at Memorial research Medical Clinic in Long Beach, and Staff Physician at Long Beach Memorial Medical Center and the Veterans Affairs Medical Center. He is also a founding partner of Integrium, a research organisation which focuses on clinical trials in cardiovascular and metabolic disease. A prominent advocate of the need for combination therapy in the management of hypertension, Dr. Neutel has researched and lectured extensively on the subject and has authored numerous abstracts, journal articles and book chapters. He has also been a reviewer and served on the editorial boards for a number of high profile journals. A prolific researcher, he has carried out extensive research in areas such as cardiovascular medicine, endocrinology, and central nervous system disorders.

​1. State of Hypertension Control in 2007.- 2. Historical Review of Combination Therapy.- 3. Advantages of Combination Therapy and Monotherapy.- 4. Use of Combination Therapy and Monotherapy.- 5. Outcome Studies with Combination Therapy.- 6. USe of Combination Therapy as First Line Treatment.- 7. Available Combination Agents.

Erscheint lt. Verlag 17.12.2013
Zusatzinfo VII, 84 p. 43 illus., 3 illus. in color.
Verlagsort Tarporley
Sprache englisch
Themenwelt Medizin / Pharmazie Gesundheitswesen
Medizin / Pharmazie Medizinische Fachgebiete Allgemeinmedizin
Medizinische Fachgebiete Innere Medizin Kardiologie / Angiologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Studium 1. Studienabschnitt (Vorklinik) Biochemie / Molekularbiologie
Schlagworte Blood pressure • Cardiovascular • Combination Therapy • Hypertension • patients • pharmacotherapy • Polypharmacy
ISBN-10 1-908517-28-X / 190851728X
ISBN-13 978-1-908517-28-9 / 9781908517289
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 7,3 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
'Ars echocardiographica' - Schritt für Schritt zur …

von Andreas Hagendorff; Stephan Stoebe

eBook Download (2021)
Urban & Fischer Verlag - Fachbücher
CHF 126,95